Prominent investors criticize Lundbeck's share structure split

Pharmaceutical firm Lundbeck’s recently proposed split share structure has not been well received by some big investors.
Photo: Lundbeck / PR
Photo: Lundbeck / PR
by CHRISTIAN BUNDGAARD, translated by daniel pedersen

Last week, Lundbeck announced a new share structure dividing shares into two categories, which would allow the company to hunt for external financing without the Lundbeck Foundation, which is the majority shareholder, having to relinquish any power.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading